Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06887465

Non-invasive and Continuous Blood Pressure Monitoring

The goal of this observational study is to evaluate the accuracy and reliability of the VeriTrack non-invasive blood pressure monitor compared to radial arterial catheterization in adult surgical patients.

The main question it aims to answer is:

How well does VeriTrack measure continuous blood pressure compared to an arterial catheter?

Researchers will compare VeriTrack readings to arterial line measurements to determine if the VeriTrack provides comparable accuracy and clinical utility.

Participants will wear the VeriTrack device during surgery and have a radial arterial catheter placed as part of standard care.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Blood Pressure

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location contact

Jeffrey Joseph, DO

PRINCIPAL_INVESTIGATOR

Jennifer Lessin, RN

CONTACT

[email protected]

215-955-6161

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients whose blood pressure will be monitored using an arterial line during their procedure
  • Patients who have a palpable dorsalis pedis pulse

Exclusion criteria

  • Patients who have non-palpable dorsalis pedis pulses
  • Patients whose limbs are inaccessible for placement of Vena Vitals Wearable
  • Patients with known allergy to adhesives and/or silicone

Treatment and study plan

non-invasive blood pressure monitor

Device

Application of the VeriTrack non-invasive blood pressure monitor

Primary outcomes

  1. Accuracy of the VeriTrack device in continuous blood pressure monitoring

    Time frame: 1-24 hours

    Systolic, diastolic, and mean arterial pressure (MAP) values will be compared between the VeriTrack and the arterial line using a Bland-Altman analysis.

Secondary outcomes

  1. Blood Pressure Change Accuracy

    Time frame: 1-24 hours

    Changes in sys, dia, and MAP measured by VeriTrack will be evaluated and compared to the changes measured by the arterial line

Sponsors and collaborators

Lead sponsor

Vena Vitals

Industry

Collaborators

  • Thomas Jefferson University

Registry information

Official study title

Comparison of Non-Invasive Wearable Sensors to Radial Arterial Catheterization on Human Subjects

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 20, 2025
Registry last updated
Apr 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.